SCHMID HANS P 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Mar 10, 2009
Insider Transaction Report
Form 4
SCHMID HANS P
Pres & Mng Dir, SciClone Int'l
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2009-03-06+125,000→ 125,000 totalExercise: $1.08Exp: 2019-03-06→ Common Stock (125,000 underlying) - Award
Non-Qualified Stock Option (right to buy)
2009-03-06+125,000→ 125,000 totalExercise: $1.08Exp: 2019-03-06→ Common Stock (125,000 underlying)
Footnotes (3)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
- [F3]Provided employee remains employed by the Company, the Option will vest based on the achievement of SciClone Pharmaceuticals International Ltd. achieving annual sales of a) $75 million and b) $85 million (each such milestone triggering vesting of 50,000 and 75,000 shares, respectively) before December 31, 2011 (the "Performance-Based Option"). If the Performance-Based Option is not achieved on or before December 31, 2011, the Option will not vest and will terminate at that time.